DF/HCC Limited Opportunity: DCCPS Supplements
The following NCI Division of Cancer Control and Population Sciences P30 supplement announcements have been released, and DF/HCC has been granted 1 nomination per opportunity. Please read the summaries below and click to download the RFA for any that are of interest.
Pre-Submission Informational Webinar
An informational webinar will be held regarding the COE opportunity on Monday, April 19, 2021, 1:30 PM EST. Please see the COE RFA document below for password and call-in information.
DF/HCC LOI & Internal Deadline
DF/HCC may submit one application for each of these supplements, and as such requires an internal vetting process to determine which applications to put forward, with the following key dates:
Letter of Intent (LOI) to DF/HCC: April 15, 2021 (5pm) to firstname.lastname@example.org
DF/HCC Nominated Applicants Notified: April 23, 2021
Full Application Deadline to NCI: May 21, 2021
The LOI should be submitted to Deborah Goff, PhD via email no later than April 15, 2021 at 5pm and should contain the following:
- Name, academic title, institutional affiliation
- Supplement Opportunity for which you would like to be considered
- Title plus one-page description of project
- NIH biosketch for key project personnel